3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Risk Reduction: new trials by email Literature Review of Risk Reduction trials Research Report on Risk Reduction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low Dose Tamoxifen for Mammographic Density Reduction Tamoxifen Oral Tablet, Placebo Oral Tablet - Risk Reduction, Mammographic Density Reduction | Phase 2 | Completed | Per Hall | 1440 | 2016-11-01 | 2025-03-07 |
| BEing Safe in Treatment BEST assessment only, BEST assessment plus feedback report, Standard Counselor Training - Risk Behavior, Sex, Unsafe | Phase 2 | Completed | University of Washington | 537 | 2015-06-01 | 2018-07-02 |
| Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W) PROJECT POWER, Power Health - Unsafe Sex, Risk Reduction | Phase 1 / Phase 2 | Completed | Nova Southeastern University | 211 | 2011-07-01 | 2014-03-11 |
Risk Reduction Behavior (3) · Unsafe Sex (2) · Breast Neoplasms (1) · Risk-Taking (1) · Substance-Related Disorders (1)
Behavior (3) · Sexual Behavior (2) · Breast Diseases (1) · Chemically-Induced Disorders (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Advance Directives (1) · Tamoxifen (1)
Nova Southeastern University (1) · Per Hall (1) · University of Washington (1)
United States (1)
PMID 33734864, PMID 35751944, PMID 36637153, PMID 37149701, PMID 38554131, PMID 39593191, PMID 42720596
2016 (1), R01HD078163 (1)